Anti‐IL5 therapies for asthma

Overview of attention for article published in Cochrane database of systematic reviews, September 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

So far, Altmetric has seen 4 public wall posts from 3 users.

Anti-IL5 terapije za…

New #CochraneEvidence: Anti-IL5 therapies for asthma http://ow.ly/GHzX30foCj6

This is an update of a review on mepolizumab for asthma - now expanded to include reslizumab and benralizumab ow.ly/GHzX30foCj6

New #CochraneEvidence: Anti-IL5 therapies for asthma http://ow.ly/GHzX30foCj6

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.